Background Banner

BSE                                     ...

Published: Sep 07, 2005

BSE                                                                                                

FSIS Allows Small Intestine Except Distal Ileum

The U.S. Department of Agriculture (USDA) Food Safety and Inspection Service (FSIS) today (September 7) published an amendment to the interim final rule “Prohibition on the Use of Specified Risk Materials for Human Food.” The new amendment continues to prohibit the distal ileum, a specified risk material (SRM), for use as human food but allows use of the remainder of the beef small intestine from cattle that are slaughtered in the U.S. or in a foreign establishment eligible to export such products. The U.S. Food and Drug Administration published a similar amendment today, to the small intestine provisions of its interim final rule on bovine spongiform encephalopathy (BSE).

FSIS has determined that the portion of the small intestine traditionally used as food, or as a casing for specialty sausage, can be safely and effectively separated from the section that contains the distal ileum. The distal ileum, but not the remainder of the small intestine, was one of the tissues of cattle that FSIS classified as an SRM associated with BSE in January 2004. In the January 2004 interim final rule, FSIS asked for comments on procedures for effectively separating the small intestine from the distal ileum.

For more details, read the online FSIS news release.

BSE                                                                                                

FSIS Allows Small Intestine Except Distal Ileum

The U.S. Department of Agriculture (USDA) Food Safety and Inspection Service (FSIS) today (September 7) published an amendment to the interim final rule “Prohibition on the Use of Specified Risk Materials for Human Food.” The new amendment continues to prohibit the distal ileum, a specified risk material (SRM), for use as human food but allows use of the remainder of the beef small intestine from cattle that are slaughtered in the U.S. or in a foreign establishment eligible to export such products. The U.S. Food and Drug Administration published a similar amendment today, to the small intestine provisions of its interim final rule on bovine spongiform encephalopathy (BSE).

FSIS has determined that the portion of the small intestine traditionally used as food, or as a casing for specialty sausage, can be safely and effectively separated from the section that contains the distal ileum. The distal ileum, but not the remainder of the small intestine, was one of the tissues of cattle that FSIS classified as an SRM associated with BSE in January 2004. In the January 2004 interim final rule, FSIS asked for comments on procedures for effectively separating the small intestine from the distal ileum.

For more details, read the online FSIS news release.